focus -WSS

focus

author：leisure time 2025-10-02 00:51:55 - browse：5

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company amid a wave of consumer complaints about patients receiving incorrect medicines or being unable to get their prescriptions filled.

Elevance did not confirm Marchetti’s departure as the president of CarelonRx, but according to his Linkedin profile, he left the company in May.

Elevance, the second-largest commercial health insurer in the country by market share, uses its CarelonRx subsidiary to manage its pharmacy business. In online complaints, CarelonRx customers point toward January 1 as the date when issues with obtaining their prescriptions from the company began. The reported problems include safety issues like receiving other people’s medications or receiving medications they discontinued years ago.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： More tobacco lobbyists active in statehouses

WSS

As Maui death toll rises, number of missing remains unclear

H5N1 bird flu found in pasteurized milk: what we know

Hilary may become 1st tropical storm to make landfall in California in 84 years

ActiGraph execs on goal of drug approvals with digital endpoints

Beware the threat of staffing cuts at the CDC

Trump cancels press conference intended to dispute Georgia election interference charges

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Beware the threat of staffing cuts at the CDC

Drug repurposing or repositioning? The language matters

Cancer drug shortages' outsize impact on ovarian cancer patients

Medical leaders decry Supreme Court decision on affirmative action

Close Medicare's dangerous gaps in addiction treatment coverage

BioMarin wins approval for gene therapy to treat hemophilia A

Patient advocates sound warning on FDA proposal on salt intake

Virginia high school admissions case could be legal follow

Majority of Americans think Trump's Ga. election interference case is serious: POLL

explore

ProMED sees offers of support, but its future remains unclear

Health care needs a new profession: neuroimaging counseling

Why does health care cost so much? A reading guide

Element Biosciences CEO lays out genome sequencing strategy

Clinical trials must include more disabled people

Evacuations in place as 3 wildfires burn in eastern Washington state

focus

hotspot

hotspot

focus